The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Chemical biology of anticancer gold(iii) and gold(i) complexes
Abstract
Anticancer gold complexes, including their mechanisms of action and the approaches adopted to improve the anticancer efficiency are described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutathione Homeostasis and Functions: Potential Targets for Medical Interventions
Lushchak, V. I. (2012) · Journal of Amino Acids · doi:10.1155/2012/736837 · Cited by 1,266
multifunctional enzymes in cancer
Mohamed, M. M., & Sloane, B. F. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1949 · Cited by 1,265
Shaw, C. F. (1999) · Chemical Reviews · doi:10.1021/cr980431o · Cited by 990
On the medicinal chemistry of gold complexes as anticancer drugs
Ott, I. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.019 · Cited by 825
The Medicinal Applications of Imidazolium Carbene−Metal Complexes
Hindi, K. M., Panzner, M. J., Tessier, C. A., Cannon, C. L., & Youngs, W. J. (2009) · Chemical Reviews · doi:10.1021/cr800500u · Cited by 776
Hickey, J. L., Ruhayel, R. A., Barnard, P. J., Baker, M. V., Berners-Price, S. J., & Filipovska, A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja804027j · Cited by 599
Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs
Bindoli, A., Rigobello, M. P., Scutari, G., Gabbiani, C., Casini, A., & Messori, L. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.026 · Cited by 595
N-Heterocyclic carbene metal complexes in medicinal chemistry
Oehninger, L., Rubbiani, R., & Ott, I. (2013) · Dalton Trans. · doi:10.1039/c2dt32617e · Cited by 560
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies
Nobili, S., Mini, E., Landini, I., Gabbiani, C., Casini, A., & Messori, L. (2010) · Medicinal Research Reviews · doi:10.1002/med.20168 · Cited by 503
Gold compounds as therapeutic agents for human diseases
Berners-Price, S. J., & Filipovska, A. (2011) · Metallomics · doi:10.1039/c1mt00062d · Cited by 495
Bertrand, B., & Casini, A. (2014) · Dalton Trans. · doi:10.1039/c3dt52524d · Cited by 441
Next-Generation Metal Anticancer Complexes: Multitargeting via Redox Modulation
Romero-Canelón, I., & Sadler, P. J. (2013) · Inorganic Chemistry · doi:10.1021/ic400835n · Cited by 396
Anticancer cyclometalated complexes of platinum group metals and gold
Cutillas, N., Yellol, G. S., de Haro, C., Vicente, C., Rodríguez, V., & Ruiz, J. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.03.024 · Cited by 332
Milacic, V., Chen, D., Ronconi, L., Landis-Piwowar, K. R., Fregona, D., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3017 · Cited by 317
Mirabelli, C. K., Johnson, R. K., Sung, C. M., Faucette, L. F., Muirhead, K. A., & Crooke, S. T. (1985) · PubMed · Cited by 295
Thioredoxin System in Cell Death Progression
Lu, J., & Holmgren, A. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4650 · Cited by 279
Zhang, Z. Y., & Dixon, J. E. (1993) · Biochemistry · doi:10.1021/bi00087a012 · Cited by 273
Thiol-Reactive Metal Compounds Inhibit NF-κB Activation by Blocking IκB Kinase
Jeon, K.-I., Jeong, J.-Y., & Jue, D.-M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5981 · Cited by 226
Zou, T., Lum, C. T., Chui, S. S., & Che, C. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209787 · Cited by 222
Self-citationInhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by Auranofin
Angelucci, F., Sayed, A. A., Williams, D. L., Boumis, G., Brunori, M., Dimastrogiovanni, D., Miele, A. E., Pauly, F., & Bellelli, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020701 · Cited by 213
Undressing of Phosphine Gold( I ) Complexes as Irreversible Inhibitors of Human Disulfide Reductases
Urig, S., Fritz‐Wolf, K., Réau, R., Herold‐Mende, C., Tóth, K., Davioud‐Charvet, E., & Becker, K. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502756 · Cited by 206
Berry, M. J., Kieffer, J. D., Harney, J. W., & Larsen, P. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98657-6 · Cited by 202
Ilari, A., Baiocco, P., Messori, L., Fiorillo, A., Boffi, A., Gramiccia, M., Di Muccio, T., & Colotti, G. (2012) · Amino Acids · doi:10.1007/s00726-011-0997-9 · Cited by 188
On the Biological Properties of Alkynyl Phosphine Gold(I) Complexes
Meyer, A., Bagowski, C. P., Kokoschka, M., Stefanopoulou, M., Alborzinia, H., Can, S., Vlecken, D. H., Sheldrick, W. S., Wölfl, S., & Ott, I. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201202939 · Cited by 187
Cyclometalated gold(iii) complexes with N-heterocyclic carbene ligands as topoisomerase I poisons
Yan, J. J., Chow, A. L.-F., Leung, C.-H., Sun, R. W.-Y., Ma, D.-L., & Che, C.-M. (2010) · Chemical Communications · doi:10.1039/c001216e · Cited by 179
Self-citationLiu, N., Li, X., Huang, H., Zhao, C., Liao, S., Yang, C., Liu, S., Song, W., Lu, X., Lan, X., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2113 · Cited by 173
Thioredoxin reductase as a novel molecular target for cancer therapy
Nguyen, P., Awwad, R. T., Smart, D. D. K., Spitz, D. R., & Gius, D. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.04.028 · Cited by 172
Towards the rational design of platinum(ii) and gold(iii) complexes as antitumour agents
Wang, X., & Guo, Z. (2008) · Dalton Trans. · doi:10.1039/b715903j · Cited by 160
Stallings‐Mann, M. L., Jamieson, L., Regala, R. P., Weems, C. R., Murray, N. R., & Fields, A. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3405 · Cited by 154
Targeting Aquaporin Function: Potent Inhibition of Aquaglyceroporin-3 by a Gold-Based Compound
Martins, A. P., Marrone, A., Ciancetta, A., Galán‐Cobo, A., Echevarría, M., Moura, T. F., Re, N., Casini, A., & Soveral, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037435 · Cited by 154
Zou, T., Lum, C. T., Lok, C., To, W., Low, K., & Che, C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201400142 · Cited by 151
Self-citationStable Anticancer Gold(III)–Porphyrin Complexes: Effects of Porphyrin Structure
Sun, R. W., Li, C. K.-L., Ma, D., Yan, J. J., Lok, C., Leung, C., Zhu, N., & Che, C. (2010) · Chemistry - A European Journal · doi:10.1002/chem.200902741 · Cited by 149
Self-citationCysteine proteases as targets for metal-based drugs
Fricker, S. P. (2010) · Metallomics · doi:10.1039/b924677k · Cited by 144
Beyond platinums: gold complexes as anticancer agents.
Nardon, C., Boscutti, G., & Fregona, D. (2014) · PubMed · Cited by 136
Saggioro, D., Rigobello, M. P., Paloschi, L., Folda, A., Moggach, S. A., Parsons, S., Ronconi, L., Fregona, D., & Bindoli, A. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.08.016 · Cited by 133
Bioinorganic and medicinal chemistry: aspects of gold(i)-protein complexes
Bhabak, K. P., Bhuyan, B. J., & Mugesh, G. (2011) · Dalton Transactions · doi:10.1039/c0dt01057j · Cited by 127
Sun, R. W., Lok, C., Fong, T. T., Li, C. K.-L., Yang, Z. F., Zou, T., Siu, F., & Che, C. (2013) · Chemical Science · doi:10.1039/c3sc21972k · Cited by 113
Self-citationYan, K., Lok, C., Bierła, K., & Che, C. (2010) · Chemical Communications · doi:10.1039/c0cc01058h · Cited by 110
Self-citationGabbiani, C., Mastrobuoni, G., Sorrentino, F., Dani, B., Rigobello, M. P., Bindoli, A., Cinellu, M. A., Pieraccini, G., Luigi Messori, A., & Casini, A. (2010) · MedChemComm · doi:10.1039/c0md00181c · Cited by 110
He, L., Chen, T., You, Y., Hu, H., Zheng, W., Kwong, W., Zou, T., & Che, C. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201407143 · Cited by 109
Self-citationKöster, S. D., Alborzinia, H., Can, S., Kitanović, I., Wölfl, S., Rubbiani, R., Ott, I., Riesterer, P., Prokop, A., Merz, K., et al. (2012) · Chemical Science · doi:10.1039/c2sc01127a · Cited by 105
Phosphine-Gold(I) Compounds as Anticancer Agents: General Description and Mechanisms of Action
Lima, J. C., & Rodríguez, L. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011797927670 · Cited by 101
Selective Targeting of the Cysteine Proteome by Thioredoxin and Glutathione Redox Systems
Go, Y., Roede, J. R., Walker, D. I., Duong, D. M., Seyfried, N. T., Orr, M. L., Liang, Y., Pennell, K. D., & Jones, D. P. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.030437 · Cited by 97
Organogold(III) Supramolecular Polymers for Anticancer Treatment
Zhang, J., Lu, W., Sun, R. W., & Che, C. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201108466 · Cited by 97
Self-citationZhang, J., Sun, R. W., & Che, C. (2012) · Chemical Communications · doi:10.1039/c2cc00029f · Cited by 87
Self-citationThe mode of action of anticancer gold-based drugs: a structural perspective
Luigi Messori, A., Scaletti, F., Massai, L., Cinellu, M. A., Gabbiani, C., Vergara, A., & Merlino, A. (2013) · Chemical Communications · doi:10.1039/c3cc46400h · Cited by 83
Chen, X., Shi, X., Zhao, C., Li, X., Lan, X., Liu, S., Huang, H., Liu, N., Liao, S., Zang, D., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2361 · Cited by 82
Karver, M. R., Krishnamurthy, D., Kulkarni, R. A., Bottini, N., & Barrios, A. M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901220m · Cited by 79
Gold(III) compound is a novel chemocytotoxic agent for hepatocellular carcinoma
Lum, C. T., Yang, Z. F., Li, G. H., Sun, R. W., Fan, S. T., Poon, R. T. P., Lin, M. C. M., Che, C., & Kung, H. F. (2005) · International Journal of Cancer · doi:10.1002/ijc.21484 · Cited by 77
Self-citationAnticancer gold(i)–phosphine complexes as potent autophagy-inducing agents
Tian, S., Siu, F., Kui, S. C. F., Lok, C., & Che, C. (2011) · Chemical Communications · doi:10.1039/c1cc11820j · Cited by 68
Self-citationAkerman, K. J., Fagenson, A. M., Cyril, V., Taylor, M., Muller, M. T., Akerman, M. P., & Munro, O. Q. (2014) · Journal of the American Chemical Society · doi:10.1021/ja412350f · Cited by 67
Liu, R., Wang, Y., Yuan, Q., An, D., Li, J., & Gao, X. (2014) · Chemical Communications · doi:10.1039/c4cc03320e · Cited by 64
Iminophosphorane–organogold(III) complexes induce cell death through mitochondrial ROS production
Vela, L., Contel, M., Palomera, L., Azaceta, G., & Marzo, I. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.06.004 · Cited by 62
Enhancement of anticancer efficacy using modified lipophilic nanoparticle drug encapsulation
Wong, K. K., Lee, Zhang, Liu, X., Sun, R. W. Y., & Che, C. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28783 · Cited by 58
Self-citationLuigi Messori, A., Scaletti, F., Massai, L., Cinellu, M. A., Krauss, I. R., di Martino, G., Vergara, A., Paduano, L., & Merlino, A. (2013) · Metallomics · doi:10.1039/c3mt00265a · Cited by 55
Lum, C. T., Liu, X., Sun, R. W., Li, X., Peng, Y., He, M., Kung, H. F., Che, C., & Lin, M. C. M. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.01.033 · Cited by 45
Self-citationDeubiquitinases as potential anti-cancer targets for gold(III) complexes.
Zhang, J.-J., Ng, K., Lok, C.-N., Sun, R. W., & Che, C. (2013) · Chemical Communications · doi:10.1039/c3cc41766b · Cited by 43
Self-citationGamberi, T., Massai, L., Magherini, F., Landini, I., Fiaschi, T., Scaletti, F., Gabbiani, C., Bianchi, L., Bini, L., Nobili, S., et al. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.03.032 · Cited by 37
A Synthetic Model for the Inhibition of Glutathione Peroxidase by Antiarthritic Gold Compounds
Bhabak, K. P., & Mugesh, G. (2009) · Inorganic Chemistry · doi:10.1021/ic8019183 · Cited by 34
Gold(III) porphyrin 1a prolongs the survival of melanoma-bearing mice and inhibits angiogenesis
Lum, C. T., Huo, L., Sun, R. W., Li, M., Kung, H. F., Che, C., & Lin, M. C. M. (2010) · Acta Oncologica · doi:10.3109/0284186x.2010.537693 · Cited by 34
Self-citationLi, W., Xie, Y., Sun, R. W., Liu, Q., Young, J., Yu, W., Che, C., Tam, P., & Ren, Y. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605147 · Cited by 33
Self-citationTarget selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes
Ringhieri, P., Iannitti, R., Nardon, C., Palumbo, R., Fregona, D., Morelli, G., & Accardo, A. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.07.014 · Cited by 30
Cited by
Photosensitizers for Photodynamic Therapy
Lan, M., Zhao, S., Liu, W., Lee, C., Zhang, W., & Wang, P. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900132 · Cited by 1,081
Metal complexes in cancer therapy – an update from drug design perspective
Ndagi, U., Mhlongo, N., & Soliman, M. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s119488 · Cited by 935
Zhou, J., Yu, G., & Huang, F. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00898d · Cited by 677
Makovec, T. (2019) · Radiology and Oncology · doi:10.2478/raon-2019-0018 · Cited by 480
Targeting the Thioredoxin System for Cancer Therapy
Zhang, J., Li, X., Han, X., Liu, R., & Fang, J. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.06.001 · Cited by 460
Self-citation
Metadata
- Authors
- Zou, T., Lum, C. T., Lok, C.-N., Zhang, J.-J., & Che, C.-M.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2015
- Volume
- 44
- Issue
- 24
- Pages
- 8786-8801
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2122674062
- Cited by
- 628
- References
- 62
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.